A role for protein kinase C in the multidrug resistance phenotype of human carcinoma KB cell lines.
Drew
L
L
Department of Biology, University of York, England.
Warr
J R
JR
Rumsby
M G
MG
D000470:Alkaloids / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D003078:Colchicine / Q000494:pharmacology; D003630:Daunorubicin / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D010641:Phenotype; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D019311:Staurosporine; D014407:Tumor Cells, Cultured; D014747:Vinblastine / Q000494:pharmacology
D000470:Alkaloids; D004791:Enzyme Inhibitors; D007211:Indoles; D014747:Vinblastine; D004317:Doxorubicin; D011493:Protein Kinase C; D019311:Staurosporine; D003078:Colchicine; C064758:Ro 31-8220; D003630:Daunorubicin